phorbol 12,13-dibutyrate has been researched along with desipramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Kamatchi, GL; Ticku, MK | 1 |
| Hrdina, PD; Mann, CD; Vu, TB | 1 |
1 review(s) available for phorbol 12,13-dibutyrate and desipramine
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
2 other study(ies) available for phorbol 12,13-dibutyrate and desipramine
| Article | Year |
|---|---|
Tricyclic antidepressants inhibit Ca(2+)-activated K(+)-efflux in cultured spinal cord neurons.
Topics: Adenylate Cyclase Toxin; Animals; Antidepressive Agents, Tricyclic; Calcimycin; Calcium; Cells, Cultured; Colforsin; Desipramine; Embryo, Mammalian; Female; Kinetics; Male; Mice; Mice, Inbred C57BL; Neurons; Pertussis Toxin; Phorbol 12,13-Dibutyrate; Potassium; Potassium Channels; Rubidium; Spinal Cord; Virulence Factors, Bordetella | 1991 |
Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
Topics: Amphetamines; Animals; Antidepressive Agents; Autoradiography; Binding, Competitive; Cerebral Cortex; Desipramine; Fluoxetine; Hippocampus; Injections, Intraperitoneal; Male; Paraventricular Hypothalamic Nucleus; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Signal Transduction | 1995 |